According to the latest report by IMARC Group, titled “Antifungal Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, offers a comprehensive analysis of the industry, which comprises insights on the market. The report also includes competitor and regional analysis, and contemporary advancements in the market.
How big is the antifungal drugs market?
The global antifungal drugs market size reached US$ 14.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 18.0 Billion by 2028, exhibiting a growth rate (CAGR) of 3.5% during 2023-2028.
What are antifungal drugs?
Fungal infection is caused by the overgrowth of fungi in the body. Antifungal drugs are primarily used to treat and prevent fungal infections, such as ringworm, fungal meningitis, athlete’s foot, nail infections, candidiasis, and cryptococcal meningitis. They are typically formulated from natural or synthetic compounds and can be administered orally or through injectables or applied topically. Antifungal drugs can be classified into three classes based on their site of action, including azoles, polyenes, and allylamines. Some of the commonly available product variants include terbinafine, fluconazole, ketoconazole, and itraconazole. Currently, antifungal drugs are available in over-the-counter (OTC) capsules, liquid, gel, spray, cream, and intravenous (IV) injection variants.
Get the Sample Report: https://www.imarcgroup.com/antifungal-drugs-market/requestsample
What are the growth prospects and trends in the antifungal drugs industry?
The escalating prevalence of nosocomial and fungal infections is one of the key factors driving the market growth. Additionally, public and private organizations are actively working to raise awareness regarding fungal illnesses and their appropriate treatments, which is supporting the market growth. Furthermore, governments of various nations are heavily funding antifungal drug research and development (R&D) activities, which, in turn, is boosting the market growth.
Besides this, the rising incidences of fungal infections, particularly among immunocompromised individuals, and the emergence of drug-resistant fungal strains are other growth-inducing factors. Moreover, the increasing popularity of herbal and alternative medicine, including natural antifungal agents, and surging access to antifungal treatments are creating a positive outlook for the market.
Who are the key players operating in the industry?
Antifungal Drugs Companies:
- Abbott Laboratories
- Arcadia Consumer Healthcare Inc.
- Astellas Pharma Inc.
- Bayer AG
- GlaxoSmithKline Plc
- Merck & Co. Inc.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Scynexis Inc.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Drug Class:
- Azoles
- Echinocandins
- Polyenes
- Allylamines
- Others
Breakup by Indication:
- Dermatophytosis
- Aspergillosis
- Candidiasis
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:134 N 4th St.
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com